Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density

Table 2 Dual X-ray absorptiometry parameters and Fracture Risk Assessment tool scores in postmenopausal women with type 2 diabetes depending on trabecular bone score values

Parameter	Women with TBS > 1.31 (n = 53)	Women with TBS ≤ 1.31 (n = 43)	P value
TBS	1.465 (1.39; 1.514)	1.206 (1.127; 1.271)	< 0.001
T-score, minimal	0.0 (-0.5; 0.5)	-0.2 (-0.6; 0.3)	0.42
T-score, L1-L4	0.9 (0.1; 1.7)	1.0 (0.1; 1.7)	0.84
T-score, femoral neck	0.1 (-0.2; 0.7)	-0.05 (-0.5; 0.5)	0.42
T-score, total femur	1.3 (0.85; 1.6)	1.3 (0.6; 1.8)	0.97
T-score, radius	0.3 (-0.3; 0.7)	-0.05 (-0.7; 0.7)	0.27
BMD, L1-L4 (g/cm2)	1.278 (1.197; 1.387)	1.317 (1.205; 1.39)	0.86
BMD, neck (g/cm2)	1.044 (1.011; 1.129)	1.045 (0.968; 1.105)	0.45
BMD, total femur (g/cm2)	1.173 (1.099; 1.210)	1.178 (1.088; 1.237)	0.85
BMD, radius, (g/cm2)	0.897 (0.849; 0.939)	0.873 (0.816; 0.938)	0.27
FRAX major (%)	6.1 (5.7; 6.8)	6.4 (5.7; 7.1)	0.38
FRAX hip (%)	0.1 (0.1; 0.3)	0.3 (0.1; 0.4)	0.08
FRAX major, TBS-adjusted (%)	5.1 (4.6; 6.0)	7.8 (6.9; 9.2)	< 0.001
FRAX hip, TBS-adjusted (%)	0.1 (0.0; 0.2)	0.4 (0.2; 0.6)	< 0.001

Data are presented as medians (25; 75 percentiles). TBS: Trabecular bone score; BMD: Bone mineral density; FRAX: The Fracture Risk Assessment Tool; FRAX hip: 10-year risk of hip low-energy fractures; FRAX major: 10-year risk of major low-energy fractures.